To block infection from HIV, a successful vaccine will require a combination of ingredients, including at least three antibody targets and a substance that boosts immune responses.
Duke Human Vaccine Institute expands to new Research Triangle Park campus dukechronicle.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dukechronicle.com Daily Mail and Mail on Sunday newspapers.
Duke University: Duke Opens New Research Campus in Research Triangle Park indiaeducationdiary.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiaeducationdiary.in Daily Mail and Mail on Sunday newspapers.
Duke Opens New Research Campus in Research Triangle Park | Duke School of Medicine duke.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from duke.edu Daily Mail and Mail on Sunday newspapers.
E-Mail DURHAM, N.C. - A newly identified group of antibodies that binds to a coating of sugars on the outer shell of HIV is effective in neutralizing the virus and points to a novel vaccine approach that could also potentially be used against SARS-CoV-2 and fungal pathogens, researchers at the Duke Human Vaccine Institute report. In a study appearing online May 20 in the journal Cell, the researchers describe an immune cell found in both monkeys and humans that produces a unique type of anti-glycan antibody. This newly described antibody has the ability to attach to the outer layer of HIV at a patch of glycans the chain-like structures of sugars that are on the surfaces of cells, including the outer shells of viruses.